The Teal project brought together the Roche Team, Christian Action, University of Hong Kong, Karen Leung Foundation and Central Health to offer Co-testing for HPV to hundreds of under privileged women in the busy city of Hong Kong. Their efforts constituted a fight against one of the most common but preventable cancers affecting women.
Pap in the City: a journey to co-testing for HPV in Hong Kong Read More »
Continual influenza and RSV surveillance will contribute to monitoring the incidence pattern of the emerging/reemerging strains. This supports preventive and control measures, such as the selection of antiviral drugs used and the vaccine strategies for influenza virus infection.
Molecular epidemiology of Influenza and RSV in Thailand Read More »
Point-of-care diagnostics are now capable of providing “laboratory quality” molecular pathogen detection capabilities for the ED and outpatient settings. Successful deployment enables a significant reduction in unnecessary multiplex respiratory pathogen testing, resulting in cost savings and improvement in therapeutic turnaround time.
Flu management excellence in the emergency department Read More »
HPV DNA testing is shown to be significantly more effective compared to pap smear/cytology for cervical cancer screening. In this webinar, you will learn how to implement HPV DNA testing as a primary screening tool for cervical cancer. How to address multidisciplinary challenges during the transition phase from pap smear/cytology to HPV DNA testing? What are the considerations
How to implement HPV DNA testing as a primary screening tool? Read More »
The molecular pathology laboratory at Atrium Health is one of the largest full-service molecular pathology labs in the US and receives samples from the states of North and South Carolina. We run 750,000 tests per year and are very involved in clinical trial programs. In addition, the cytogenetics laboratory is one of the largest non-commercial
Redesigning an American molecular pathology and cytogenetics lab with Lean Six Sigma Read More »
Full presentation by Dr. Virginia (Jennie) Thurston delivered to healthcare and laboratory medicine leaders at the Roche Efficiency Days (RED) 2018: REDefining perspectives in Guangzhou, China. Esoteric laboratory testing, including molecular pathology and cytogenetics, is a frequently overlooked area for continuous process improvement as it is viewed as a relatively low volume, highly complex field in comparison to other laboratory
Continuous process improvement in cytogenetics and molecular pathology Read More »
Subscribe to Lab Insights latest news and update
Join over 3,000 HCPs receiving insights in their inbox.
